Search Results

There are 2874 results for: content related to: Synthesis of Sitagliptin, the Active Ingredient in Januvia® and Janumet®

  1. Effect of a Single Cyclosporine Dose on the Single-Dose Pharmacokinetics of Sitagliptin (MK-0431), a Dipeptidyl Peptidase-4 Inhibitor, in Healthy Male Subjects

    The Journal of Clinical Pharmacology

    Volume 47, Issue 2, February 2007, Pages: 165–174, Dr Rajesh Krishna, Dr Arthur Bergman, Dr Patrick Larson, Mr Josee Cote, Dr Kenneth Lasseter, Ms Stacey Dilzer, Dr Amy Wang, Dr Wei Zeng, Mr Li Chen, Dr John Wagner and Dr Gary Herman

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006296523

  2. You have free access to this content
    Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial

    Diabetes, Obesity and Metabolism

    Volume 9, Issue 2, March 2007, Pages: 194–205, M. A. Nauck, G. Meininger, D. Sheng, L. Terranella, P. P. Stein and Sitagliptin Study 024 Group

    Version of Record online : 26 JAN 2007, DOI: 10.1111/j.1463-1326.2006.00704.x

  3. Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 10, October 2008, Pages: 959–969, R. Scott, T. Loeys, M. J. Davies, S. S. Engel and for the Sitagliptin Study 801 Group

    Version of Record online : 14 JAN 2008, DOI: 10.1111/j.1463-1326.2007.00839.x

  4. You have free access to this content
    Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin

    Diabetes, Obesity and Metabolism

    Volume 9, Issue 5, September 2007, Pages: 733–745, K. Hermansen, M. Kipnes, E. Luo, D. Fanurik, H. Khatami, P. Stein and Sitagliptin Study 035 Group

    Version of Record online : 26 JUN 2007, DOI: 10.1111/j.1463-1326.2007.00744.x

  5. Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 12, December 2013, Pages: 1101–1110, M. Alba, B. Ahrén, S. E. Inzucchi, Y. Guan, M. Mallick, L. Xu, E. A. O'Neill, D. E. Williams-Herman, K. D. Kaufman and B. J. Goldstein

    Version of Record online : 18 JUL 2013, DOI: 10.1111/dom.12145

  6. You have full text access to this Open Access content
    Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes

    Journal of Diabetes Investigation

    Volume 2, Issue 5, October 2011, Pages: 381–390, Atsunori Kashiwagi, Takashi Kadowaki, Naoko Tajima, Kenji Nonaka, Tadaaki Taniguchi, Mikio Nishii, Juan Camilo Arjona Ferreira and John M Amatruda

    Version of Record online : 8 APR 2011, DOI: 10.1111/j.2040-1124.2011.00120.x

  7. You have full text access to this Open Access content
    Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients

    Journal of Diabetes Investigation

    Volume 3, Issue 6, December 2012, Pages: 503–509, Akira Kubota, Hajime Maeda, Akira Kanamori, Kiyokazu Matoba, Yasuyuki Jin, Fuyuki Minagawa, Mitsuo Obana, Kotaro Iemitsu, Shogo Ito, Hikaru Amamiya, Mizuki Kaneshiro, Masahiko Takai, Hideaki Kaneshige, Kazuhiko Hoshino, Masashi Ishikawa, Nobuaki Minami, Tetsuro Takuma, Nobuo Sasai, Sachio Aoyagi, Takehiro Kawata, Atsuko Mokubo, Hiroshi Takeda, Shin Honda, Hideo Machimura, Tetsuya Motomiya, Manabu Waseda, Yoshikazu Naka, Yasushi Tanaka, Yasuo Terauchi and Ikuro Matsuba

    Version of Record online : 26 JUN 2012, DOI: 10.1111/j.2040-1124.2012.00221.x

  8. You have full text access to this Open Access content
    Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes

    Journal of Diabetes Investigation

    Volume 4, Issue 6, November 2013, Pages: 595–604, Naoko Tajima, Takashi Kadowaki, Taro Okamoto, Asako Sato, Kotoba Okuyama, Toshiomi Minamide and Juan Camilo Arjona Ferreira

    Version of Record online : 21 JUL 2013, DOI: 10.1111/jdi.12116

  9. Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP-4 Inhibitor Sitagliptin in Middle-Aged Obese Subjects

    The Journal of Clinical Pharmacology

    Volume 46, Issue 8, August 2006, Pages: 876–886, Dr Gary A. Herman, Dr Arthur Bergman, Dr Fang Liu, Ms Cathy Stevens, Dr Amy Q. Wang, Mr Wei Zeng, Dr Li Chen, Ms Karen Snyder, Ms Deborah Hilliard, Mr Michael Tanen, Dr Wesley Tanaka, Dr Alan G. Meehan, Dr Kenneth Lasseter, Ms Stacy Dilzer, Dr Robert Blum and Dr John A. Wagner

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006289850

  10. Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 6, June 2012, Pages: 481–492, K. R. Gerrald, E. Van Scoyoc, R. C. Wines, T. Runge and D. E. Jonas

    Version of Record online : 27 DEC 2011, DOI: 10.1111/j.1463-1326.2011.01540.x

  11. You have free access to this content
    Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 5, May 2010, Pages: 442–451, D. Williams-Herman, J. Johnson, R. Teng, G. Golm, K. D. Kaufman, B. J. Goldstein and J. M. Amatruda

    Version of Record online : 28 JAN 2010, DOI: 10.1111/j.1463-1326.2010.01204.x

  12. Multiple Doses of Sitagliptin, a Selective DPP-4 Inhibitor, Do Not Meaningfully Alter Pharmacokinetics and Pharmacodynamics of Warfarin

    The Journal of Clinical Pharmacology

    Volume 49, Issue 10, October 2009, Pages: 1157–1167, D. Hamish Wright, Gary A. Herman, Andrea Maes, Qi Liu, Amy O. Johnson-Levonas and John A. Wagner

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009341653

  13. Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 5, May 2012, Pages: 409–418, J. Wainstein, L. Katz, S. S. Engel, L. Xu, G. T. Golm, S. Hussain, E. A. O’Neill, K. D. Kaufman and B. J. Goldstein

    Version of Record online : 22 DEC 2011, DOI: 10.1111/j.1463-1326.2011.01530.x

  14. Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 6, June 2013, Pages: 531–537, L. Ohlsson, W. Alsalim, R. D. Carr, A. Tura, G. Pacini, A. Mari and B. Ahrén

    Version of Record online : 7 FEB 2013, DOI: 10.1111/dom.12062

  15. Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 7, July 2008, Pages: 545–555, J. C. N. Chan, R. Scott, J. C. Arjona Ferreira, D. Sheng, E. Gonzalez, M. J. Davies, P. P. Stein, K. D. Kaufman, J. M. Amatruda and D. Williams-Herman

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1463-1326.2008.00914.x

  16. You have free access to this content
    Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 3, March 2010, Pages: 252–261, P. Aschner, H. L. Katzeff, H. Guo, S. Sunga, D. Williams-Herman, K. D. Kaufman, B. J. Goldstein and for the Sitagliptin Study 049 Group

    Version of Record online : 25 NOV 2009, DOI: 10.1111/j.1463-1326.2009.01187.x

  17. You have full text access to this OnlineOpen article
    Short- and long-term effect of sitagliptin after near normalization of glycemic control with insulin in poorly controlled Japanese type 2 diabetic patients

    Journal of Diabetes Investigation

    Volume 5, Issue 5, September 2014, Pages: 548–553, Keiko Fujisawa, Tetsuyuki Yasuda, Hideaki Kaneto, Naoto Katakami, Mayumi Tsuji, Fumiyo Kubo, Shugo Sasaki, Kazuyuki Miyashita, Toyoko Naka, Ryuuichi Kasami, Akio Kuroda, Munehide Matsuhisa and Iichiro Shimomura

    Version of Record online : 28 NOV 2013, DOI: 10.1111/jdi.12176

  18. Sitagliptin in the treatment of type 2 diabetes: a meta-analysis

    Journal of Evidence-Based Medicine

    Volume 5, Issue 3, August 2012, Pages: 154–165, Mei Zhan, Ting Xu, Fengbo Wu and Yao Tang

    Version of Record online : 29 AUG 2012, DOI: 10.1111/j.1756-5391.2012.01189.x

  19. You have full text access to this OnlineOpen article
    Sitagliptin attenuates sympathetic innervation via modulating reactive oxygen species and interstitial adenosine in infarcted rat hearts

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 2, February 2015, Pages: 418–429, Tsung-Ming Lee, Wei-Ting Chen, Chen-Chia Yang, Shinn-Zong Lin and Nen-Chung Chang

    Version of Record online : 11 NOV 2014, DOI: 10.1111/jcmm.12465

  20. The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 7, July 2011, Pages: 644–652, C. Reasner, L. Olansky, T. L. Seck, D. E. Williams-Herman, M. Chen, L. Terranella, A. O. Johnson-Levonas, K. D. Kaufman and B. J. Goldstein

    Version of Record online : 24 MAY 2011, DOI: 10.1111/j.1463-1326.2011.01390.x